Skip to main content
FQHC Talent

Cookie notice

Allow detailed analytics to improve the site?It's from us, Google and Vercel, and stays off until you accept. If you're signed in, it can link your visits across devices. Declining doesn't limit what you can use. Details & privacy.

Back to the news
Funding & Budget

HRSA takes first step to restart the 340B rebate pilot

Federal

Issue

340B drug pricingIn court

Next: · Amgen to request 340B visit claims data starting November 15

HRSA posted a revised 340B rebate pilot application package in the Federal Register on June 15, and comments were due July 15. A June 22 correction expects 11 manufacturer plans, up from about 8 to 9 in the first round a court vacated.

OMB finished its review in late July, but HRSA has not published the full policy.

Key points

  • HRSA is bringing back the rebate pilot a court vacated in February, and its revised package expects 11 manufacturers, up from about 8 to 9.
  • Comments were due July 15, 2026, so covered entities that opposed the first round had 13 days to respond.
  • A 90-day wait after approvals puts the earliest realistic start in late 2026 or 2027, so model the cash-flow impact now.

Sources for this story

HRSA / Federal Register

Part of

Sources for your board packet

This story's source plus 4 related stories and their sources, ready to print for your team or board.

Free. Unlocking the packet subscribes you to Intel Brief. You'll also get a short welcome series and the occasional product update. You'll be subscribed right away, with no confirmation email. Unsubscribe with one click in any issue. If you unsubscribed before, we won't re-add you. We never sell your email. You can open each source above without an email.

More in Funding & Budget

Cite this analysis

FQHC Talent. (2026, June 15). HRSA takes first step to restart the 340B rebate pilot. Source: HRSA / Federal Register. Retrieved November 11, 2026, from https://www.fqhctalent.com/intel/hrsa-340b-rebate-pilot-2-revival-icr-june-2026